BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8819893)

  • 21. Absence of the sulfate transporter SAT-1 has no impact on oxalate handling by mouse intestine and does not cause hyperoxaluria or hyperoxalemia.
    Whittamore JM; Stephens CE; Hatch M
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G82-G94. PubMed ID: 30383413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
    Sidhu H; Schmidt ME; Cornelius JG; Thamilselvan S; Khan SR; Hesse A; Peck AB
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective therapy of enteric hyperoxaluria: in vitro binding of oxalate by anion-exchange resins and aluminum hydroxide.
    Laker MF; Hofmann AF
    J Pharm Sci; 1981 Sep; 70(9):1065-7. PubMed ID: 6101157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation with chitosan-oxalate oxidase-catalase conjugate for degrading oxalate from hyperoxaluric rat chyme.
    Ramakrishnan V; Lathika KM; D'Souza SJ; Singh BB; Raghavan KG
    Indian J Biochem Biophys; 1997 Aug; 34(4):373-8. PubMed ID: 9491647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxalate dynamics in chronic renal failure. Comparison with normal subjects and patients with primary hyperoxaluria.
    Morgan SH; Purkiss P; Watts RW; Mansell MA
    Nephron; 1987; 46(3):253-7. PubMed ID: 3306417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary intake, absorption, metabolism, and excretion of oxalate.
    Williams AW; Wilson DM
    Semin Nephrol; 1990 Jan; 10(1):2-8. PubMed ID: 2404326
    [No Abstract]   [Full Text] [Related]  

  • 27. Food oxalate: factors affecting measurement, biological variation, and bioavailability.
    Massey LK
    J Am Diet Assoc; 2007 Jul; 107(7):1191-4; quiz 1195-6. PubMed ID: 17604750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transplantation procedures in primary hyperoxaluria type 1.
    Latta A; Müller-Wiefel DE; Sturm E; Kemper M; Burdelski M; Broelsch CE
    Clin Nephrol; 1996 Jul; 46(1):21-3. PubMed ID: 8832145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
    Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
    Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of dietary calcium and oxalate ratio on urinary stone formation in rats.
    Morozumi M; Ogawa Y
    Mol Urol; 2000; 4(4):313-20. PubMed ID: 11156697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate.
    Hesse A; Schneeberger W; Engfeld S; Von Unruh GE; Sauerbruch T
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S329-33. PubMed ID: 10541257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enteric hyperoxaluria: role of microbiota and antibiotics.
    Liu M; Nazzal L
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):352-359. PubMed ID: 31145706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transport of oxalate across the rabbit papillary surface epithelium.
    Chandhoke PS; Fan J
    J Urol; 2000 Nov; 164(5):1724-8. PubMed ID: 11025759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperoxaluria in patients with idiopathic calcium nephrolithiasis.
    Trinchieri A; Ostini F; Nespoli R; Rovera F; Zanetti G; Pisani E
    J Nephrol; 1998; 11 Suppl 1():70-2. PubMed ID: 9604817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Counteraction of oxalate induced nitrosative stress by supplementation of l-arginine, a potent antilithic agent.
    Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Varalakshmi P
    Clin Chim Acta; 2005 Apr; 354(1-2):159-66. PubMed ID: 15748613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conjugated bile acid replacement therapy reduces urinary oxalate excretion in short bowel syndrome.
    Emmett M; Guirl MJ; Santa Ana CA; Porter JL; Neimark S; Hofmann AF; Fordtran JS
    Am J Kidney Dis; 2003 Jan; 41(1):230-7. PubMed ID: 12500242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal oxalate absorption. I. Absorption in vitro.
    Caspary WF
    Res Exp Med (Berl); 1977 Aug; 171(1):13-24. PubMed ID: 410086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intestinal oxalate-degrading bacteria reduce oxalate absorption and toxicity in guinea pigs.
    Argenzio RA; Liacos JA; Allison MJ
    J Nutr; 1988 Jun; 118(6):787-92. PubMed ID: 3373343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
    Penniston KL; Nakada SY
    Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxalate Flux Across the Intestine: Contributions from Membrane Transporters.
    Whittamore JM; Hatch M
    Compr Physiol; 2021 Dec; 12(1):2835-2875. PubMed ID: 34964122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.